Navigation Links
MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
Date:11/7/2007

leBrook intends to actively continue its strategic evaluation process, alternatives for which include, but are not limited to, the possible sale of some or all of the Company's assets, partnering or other collaboration agreements, or a merger or other strategic transaction. There can be no assurance that the exploration of strategic alternatives at that time will result in any agreements or transactions, or that, if completed, any agreements or transactions will be successful or on attractive terms.

Transaction Terms

At the transaction closing on November 7, 2007, MiddleBrook sold certain assets, and assigned certain intellectual property rights, relating only to its existing cephalexin business, excluding cephalexin PULSYS, to Deerfield for $7.5 million, less a $500,000 payment to Deerfield. Pursuant to a consignment of those assets and license of those intellectual property rights back to the Company, the Company will continue to operate its existing cephalexin business, subject to royalty payments to Deerfield of 20% of net sales, which declines to a single digit royalty as the agreement matures. In addition, the Company granted to Deerfield a six-year warrant to purchase 3.0 million shares of the Company's common stock at $1.38, the closing market price on November 7, 2007.

If and when the Company receives approval of its Amoxicillin PULSYS New Drug Application, it may require Deerfield to acquire and license certain intellectual property rights relating only to the Company's cephalexin PULSYS business for a payment of $2.5 million. Pursuant to a sublicense of those intellectual property rights back to the Company, the Company will continue to operate its cephalexin PULSYS business. Cephalexin PULSYS is not approved for marketing by the FDA.

Deerfield also granted the Company the right to repurchase all assets and rights acquired and licensed by Deerfield for a flat purchase price of $14.0 million, if the Company has required Deerfield to
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... This is a professional and ... Omega-3 industry. The report provides a basic overview ... industry chain structure. The Omega-3 market analysis is ... competitive landscape analysis, and key regions development status. ... Company, Seadragon Marine Oils, Norwegian Fish Oil, Croda ...
(Date:5/27/2015)... May 27, 2015 With InnerVoice Communication ... environment where the message is not only heard but seen ... or virtually any motivating image. This award-winning and affordable app ... , Now, using InnerVoice Sender app in ... sent to a learner remotely for no additional cost. , ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 For a limited ... Ghasri, is now offering discounts on facial fillers. Skin loses ... the age of 18. This lost collagen can lead to ... wrinkles and expression lines. Facial fillers are an excellent way ... turn to facial fillers to create a softer and more ...
(Date:5/27/2015)... May 27, 2015 Decorview , ... America, is offering free design advice to homeowners looking ... , “Light pollution caused by streetlights, outdoor signs, ... restless night’s sleep, said Kim Rush, VP of sales ... cities across North America with recently installed LED streetlights– ...
(Date:5/27/2015)... CRN International, the radio marketing and promotions ... Financial Officer. , Prinner most recently was Principal of ... financial/operational executive positions at telecom and technology services companies ... and SNET. His accounting and consulting career began ... will be able to tap into his experience of ...
Breaking Medicine News(10 mins):Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:Decorview Helps Homeowners Combat Light Pollution 2Health News:CRN International Names New Chief Financial Officer 2
... for years may be embarrassed to let a spouse or partner ... shyness can hamper a couple,s willingness to do total body skin ... melanoma. Melanoma, the most deadly form of skin cancer, can appear ... "I had a woman tell me, ,I don,t want my husband ...
... DE May 20, 2008 A new ... therapy and fluticasone/salmeterol combination therapy, as measured by ... in the study were ages 18 years and ... been previously treated with inhaled corticosteroids.1 Results were ...
... It is not uncommon to find tissue that normally lines ... "heterotopic" gastric tissue has been identified in such diverse locations ... , This case, reported by a team led by Dr. ... edition of the World Journal of Gastroenterology. , Typically, when ...
... than a dose-response effect on mortality from alcohol-related liver ... beverage, was more significant to liver injury. , This ... You-Ming Li from Zhejiang University, is described in a ... in the World Journal of Gastroenterology. , The study ...
... with cirrhosis of the liver develop abnormally dilated blood ... vomiting may occur from the rupture of these varices, ... eradicate these varices. To achieve this, an elastic band ... allows the consecutive application of up to six rubber ...
... and calm, according to a new study from the Population ... at about age 60, participants reported more feelings of ease ... John Mirowsky, professors of sociology, have published the findings in ... issue of Social Science and Medicine. The research was funded ...
Cached Medicine News:Health News:A loving partner can save your skin 2Health News:A loving partner can save your skin 3Health News:Heterotopic gastric tissue simulating acute appendicitis 2Health News:How to save cost for esophageal varices? 2Health News:With age comes a sense of peace and calm 2
(Date:5/27/2015)... , May 27, 2015 In ... the Canadian International Pharmacy Association (CIPA) ... online from licensed Canadian pharmacies. Approximately 64% of respondents ... medications from a non-U.S. pharmacy due to costs ... not covered under their insurance plan.   ...
(Date:5/27/2015)... , May 27, 2015  Genomic Health, Inc. (Nasdaq: ... Operating Officer and Chief Financial Officer, will present at the ... City on Monday, June 1 at 8:30 a.m. ... subsequently archived webcast of the presentation, go to the  Investor ... .  Please connect to the web site at least 15 ...
(Date:5/27/2015)...  Later this week, Cardinal Health Specialty Solutions ... outcomes research (HEOR) studies that reinforce the importance ... reimbursement strategies.   Dr. Bruce ... of Cardinal Health Specialty Solutions, says that physicians, ... more than a decade that clinical trials alone ...
Breaking Medicine Technology:Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 2New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 3
...  NxStage Medical, Inc. (Nasdaq: NXTM ), a ... to release its financial results for the fourth quarter ... February 29, 2012  before the opening of the financial ... NxStage will also host a conference call at ...
... (OTC BB: IVOB), a medical device company focused on ... that the National Health Surveillance Agency (ANVISA) in Brazil ... a Class II device. This approval allows the INVOcell ... Brazil and marks a major milestone in the history ...
Cached Medicine Technology:NxStage® to Report Fourth Quarter and Full Year 2011 Financial Results 2INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA 2INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA 3
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of antibodies to Treponema pallidum in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
Medicine Products: